CA-based MedImpact Healthcare Systems, Inc acquired Elixir Solutions. This is the latest addition and part of MedImpact’s ongoing reinvestment strategy.
The acquisition expands the company’s portfolio of clinical, technology, health risk management, and consumer empowerment capabilities.
Read also – Global Lifestyle Firm Brixton Secures $15 Mn Credit Facility
Fred Howe, MedImpact Chairman and Chief Executive Officer said, “The market is asking for an alternative provider that combines innovative care solutions and connective technology without sacrificing clinical capabilities, scale, and reliability. This acquisition is the next step in offering connected care solutions to make care more personal, predictive, portable, and affordable for our clients and their members.”
MedImpact is celebrating its 35th anniversary this year. While the company began as an independent PBM startup, it has continually invested in innovation and reinvention to offer an ecosystem of total health and technology solutions to meet the needs of clients in a complex and challenging healthcare landscape.
Read also – FL-based Space Perspective Secures an Investment
MedImpact’s vision is to provide better care and better cost, one member at a time, one client at a time. MedImpact helps commercial and government health plans improve member health, manage total healthcare benefits, and reduce drug costs for millions of consumers nationwide.
About MedImpact Healthcare Systems
San Diego-based MedImpact Healthcare Systems, Inc. is the nation’s largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs.
Read also – GA-based Myavana Secures an Investment
About Elixir
With the size, adaptability, and experience to assist their clients in realizing their specific business objectives, Elixir is a pharmaceutical benefits and services provider. Their establishment was deliberate and they possess all the resources required to maximize the whole pharmaceutical care encounter.
Read also – NYC-based MIC Global Secures US$6Million in Funding
